Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage.

Annals of Clinical and Translational Neurology
Jochen A SembillHagen B Huttner

Abstract

Hematoma enlargement (HE) is associated with clinical outcomes after supratentorial intracerebral hemorrhage (ICH). This study evaluates whether HE characteristics and association with functional outcome differ in deep versus lobar ICH. Pooled analysis of individual patient data between January 2006 and December 2015 from a German-wide cohort study (RETRACE, I + II) investigating ICH related to oral anticoagulants (OAC) at 22 participating centers, and from one single-center registry (UKER-ICH) investigating non-OAC-ICH patients. Altogether, 1954 supratentorial ICH patients were eligible for outcome analyses, which were separately conducted or controlled for OAC, that is, vitamin-K-antagonists (VKA, n = 1186) and non-vitamin-K-antagonist-oral-anticoagulants (NOAC, n = 107). Confounding was addressed using propensity score matching, cox regression modeling and multivariate modeling. Main outcomes were occurrence, extent, and timing of HE (>33%/>6 mL) and its association with 3-month functional outcome. Occurrence of HE was not different after deep versus lobar ICH in patients with non-OAC-ICH (39/356 [11.0%] vs. 36/305 [11.8%], P = 0.73), VKA-ICH (249/681 [36.6%] vs. 183/505 [36.2%], P = 0.91), and NOAC-ICH (21/69 [30.4%] vs. 12...Continue Reading

References

Aug 1, 1996·Stroke; a Journal of Cerebral Circulation·R U KothariJ Khoury
Jan 1, 1997·Stroke; a Journal of Cerebral Circulation·T BrottJ Khoury
Mar 26, 2005·Stroke; a Journal of Cerebral Circulation·Matthew L FlahertyJoseph P Broderick
May 16, 2008·The New England Journal of Medicine·Stephan A MayerUNKNOWN FAST Trial Investigators
May 16, 2008·The New England Journal of Medicine·Stanley Tuhrim
Feb 8, 2013·The New England Journal of Medicine·Alfonso CicconeUNKNOWN SYNTHESIS Expansion Investigators
Feb 9, 2013·The New England Journal of Medicine·Joseph P BroderickUNKNOWN Interventional Management of Stroke (IMS) III Investigators
Feb 12, 2013·The New England Journal of Medicine·Chelsea S KidwellUNKNOWN MR RESCUE Investigators
May 30, 2013·The New England Journal of Medicine·Craig S AndersonUNKNOWN INTERACT2 Investigators
Jun 5, 2013·JAMA Neurology·Guido J FalconeJonathan Rosand
Feb 25, 2015·JAMA : the Journal of the American Medical Association·Joji B KuramatsuHagen B Huttner
Aug 6, 2015·Stroke; a Journal of Cerebral Circulation·Alastair J S WebbUNKNOWN MISTIE and CLEAR Investigators
Jan 20, 2016·International Journal of Stroke : Official Journal of the International Stroke Society·Dar DowlatshahiUNKNOWN PREDICT/Sunnybrook ICH CTA study group
Jun 9, 2016·The New England Journal of Medicine·Adnan I QureshiUNKNOWN ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network
Feb 27, 2017·Neurology·Candice DelcourtUNKNOWN INTERACT2 Investigators
Jul 7, 2017·Neurology·Jochen A SembillJoji B Kuramatsu
Dec 2, 2017·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Jochen A SembillHagen B Huttner
Jan 10, 2018·Annals of Neurology·Stefan T GernerUNKNOWN RETRACE II (German-Wide Multicenter Analysis of Oral Anticoagulation-Associated Intracerebral Hemorrhage II) Investigators
Aug 19, 2018·Lancet Neurology·Rustam Al-Shahi SalmanUNKNOWN ICH Growth Individual Patient Data Meta-analysis Collaborators
Oct 26, 2018·Stroke; a Journal of Cerebral Circulation·Maximilian I SprügelHagen B Huttner
Feb 14, 2019·Neurocritical Care·David RohJan Claassen
Apr 18, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Maximilian I SprügelHagen B Huttner
Sep 1, 2017·European Stroke Journal·Vignan YogendrakumarDar Dowlatshahi
May 17, 2019·Stroke; a Journal of Cerebral Circulation·Stefan T GernerHagen B Huttner
Jun 5, 2019·Neurocritical Care·J Claude Hemphill
Oct 9, 2019·JAMA : the Journal of the American Medical Association·Joji B KuramatsuHagen B Huttner

❮ Previous
Next ❯

Citations

Nov 23, 2020·Annals of Neurology·Jochen A SembillJoji B Kuramatsu
Oct 6, 2021·The Journal of Clinical Hypertension·Jun ShenFeng Xu

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01829581
NCT03093233
NCT03183167

Software Mentioned

SPSS
‐ widE mulTicenter Analysis of
geRman

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.